45 studies found for:    Open Studies | "Hypertriglyceridemia"
Show Display Options
Rank Status Study
21 Recruiting Novel Therapies for Metabolic Complications of Lipodystrophies
Conditions: Insulin Resistance;   Hypertriglyceridemia;   Diabetes;   Hepatic Steatosis
Interventions: Other: low-fat diet  ( Still recruiting );   Other: Diet
22 Recruiting Effects of Amino Acids on Regional Lipid Metabolism
Condition: Hypertriglyceridemia
Interventions: Dietary Supplement: Amino acids;   Dietary Supplement: Placebo
23 Unknown  Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
Condition: Hypertriglyceridemia
Interventions: Drug: Diazoxide choline;   Drug: Diazoxide choline high dose
24 Recruiting A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Condition: Hypertriglyceridemia
Interventions: Drug: Drug Omega 3;   Drug: Drug Omega-3 Comparator
25 Not yet recruiting A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD;   Hypertriglyceridemia
Interventions: Drug: Placebo;   Drug: Omega-3 carboxylic acid;   Drug: Fenofibrate 200mg
26 Recruiting Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Conditions: Metabolic Syndrome;   Dyslipidemia;   Hypertriglyceridemia
Interventions: Other: Standard reference diet;   Other: Almond supplemented diet;   Other: Low carbohydrate reference diet
27 Recruiting Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Condition: Hypertriglyceridemia
Interventions: Drug: REGN1500;   Drug: placebo
28 Unknown  Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Conditions: Hypertriglyceridaemia;   Familial Hypercholesterolaemia
Interventions: Dietary Supplement: Fish oil capsule;   Drug: HMG Coenzyme reductase
29 Recruiting An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Condition: Severe Hypertriglyceridemia
Interventions: Drug: Epanova;   Drug: Lovaza
30 Unknown  Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Condition: Coronary Artery Disease
Intervention: Drug: Omacor, omega-3 fatty acids in CAD patients
31 Recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
32 Recruiting Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Untreated Hypertriglyceridemia
Condition: Dyslipidemias
Interventions: Dietary Supplement: Astaxanthin;   Dietary Supplement: Placebo
33 Unknown  Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia
Condition: Type 2 Diabetes Mellitus ;Obesity,High Triglycerides;TCM
Interventions: Drug: Metformin;   Drug: Jiangtangtiaozhi decoction
34 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
35 Recruiting Expanded Access Metreleptin Study
Condition: Familial Partial Lipodystrophy
Intervention: Drug: Metreleptin
36 Recruiting Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 20mg;   Drug: Fenofibrate 160mg;   Other: Placebo (Fenofibrate 160 mg)
37 Recruiting Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 10mg, fenofibric acid 135mg;   Drug: atorvastatin 20mg
38 Not yet recruiting Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Condition: Type 1 Hyperlipoproteinemia
Interventions: Drug: SLx-4090 placebo;   Drug: Orlistat Placebo;   Drug: Orlistat;   Drug: Slx-4090
39 Recruiting Short-term Effects of Leptin in People With Lipodystrophy
Condition: Lipodystrophy
Intervention: Biological: Metreleptin
40 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years